论文部分内容阅读
目的:探讨血中肌钙蛋白Ⅰ(cTnⅠ)的检测在急性冠脉综合征(ACS)的诊断及临床中的应用价值。方法:选择临床诊断为ACS的患者94例,其中急性心肌梗死(AMI)35例,不稳定型心绞痛(UAP)30例,稳定型心绞痛(SAP)29例,71例健康体检作为对照组,检测其cTnⅠ的含量,并作相互比较。结果:AMI组cTnⅠ水平显著高于UAP组、SAP组和对照组(P<0.05);UAP组cTnⅠ水平显著高于SAP组和对照组(P<0.05);SAP组和对照组相比较差异无统计学意义(P>0.05)。结论:检测患者cTnⅠ水平对ACS患者疾病诊断及预后预测具有重要的临床意义。
Objective: To investigate the value of detecting cTnI in the diagnosis and clinical application of acute coronary syndrome (ACS). Methods: A total of 94 patients with ACS were enrolled. Among them, 35 cases were acute myocardial infarction (AMI), 30 cases were unstable angina pectoris (UAP), 29 cases were stable angina pectoris (SAP) and 71 cases were used as control group. The cTnI content, and for mutual comparison. Results: The cTn Ⅰ level in AMI group was significantly higher than that in UAP group, SAP group and control group (P <0.05). The level of cTn Ⅰ in UAP group was significantly higher than that in SAP group and control group (P <0.05). There was no significant difference between SAP group and control group Statistical significance (P> 0.05). Conclusion: The detection of cTn Ⅰ level in patients with ACS diagnosis and prognosis of disease has important clinical significance.